Sartorius Stedim Biotech S.A. SDMHF
249.50 USD -5.06 (-1.99%)
At closeOct 30, 2026, 4:00 PM EDT
249.50 Day range 249.50
178.30 52-week range 264.30
- YTD
- +1.42%
- 1 year
- +3.10%
- Market cap
- 24.27B
- EPS (ttm)
- 3.87
- P/E ratio
- 64.47
- YTD return
- +1.42%
- 1-year return
- +3.10%
- Volume
- 155
- Avg volume
- 1.95K
- Open
- 249.50
- Previous close
- 254.56
- Day's range
- 249.50 – 249.50
- 52-week range
- 178.30 – 264.30
- Earnings date
- Oct 22, 2026
2Y +47.11 (+23.45%)
Next earnings
Oct 22, 2026
Expected Oct 22, 2026. Consensus EPS estimate 1.38.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 22, 2026 | Sep 30, 2026 | 1.38 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 1.44 | 1.43 | -0.01 | -0.69% |
| Apr 23, 2026 | Mar 31, 2026 | 1.40 | 1.35 | -0.05 | -3.57% |
| Feb 16, 2026 | Dec 31, 2025 | 1.48 | 1.32 | -0.16 | -10.81% |
| Oct 16, 2025 | Sep 30, 2025 | 1.15 | 0.907 | -0.24 | -21.13% |
| Jul 22, 2025 | Jun 30, 2025 | 1.22 | 0.812 | -0.41 | -33.44% |
News
Baron International Growth Fund Q2 2026 Portfolio Activity 
Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript 
Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing 
Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa 
Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform 
Sartorius, Sartorius Stedim Biotech shares jump after results beat 
Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript 
Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript 
Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript 
10 stocks for investors looking for ‘wonderful companies at a fair price'
Your note
Sign in to keep a note on SDMHF — it syncs with the Stock Master app.